Bristol-Myers Squibb

Bristol-Myers Squibb Plans to Strengthen Its Operating Model in 2017
Market Realist
Wed, 12/21/16 - 10:56 am
Bristol-Myers Squibb
The Most Expensive Drugs of 2016
Motley Fool
Mon, 12/19/16 - 11:32 am
drug pricing
Gilead Sciences
Harvoni
Sovaldi
H.P. Acthar
Mallinckrodt
Shire
Cinryze
Daklinza
Bristol-Myers Squibb
Bristol-Myers Squibb to shutter ZymoGenetics' Seattle Steam Plant facility
Bizjournals.com
Thu, 12/15/16 - 10:12 am
Bristol-Myers Squibb
ZymoGenetics
Seattle
drug manufacturing
Bristol-Myers Squibb Strengthens Capabilities with Evolution of its U.S. Geographic Footprint
Yahoo
Tue, 12/13/16 - 01:16 pm
Bristol-Myers Squibb
The Year In Review: Merck Can Look Back And Smile
Forbes
Tue, 12/13/16 - 10:17 am
Merck
Keytruda
Opdivo
Bristol-Myers Squibb
Gardasil
Bristol-Myers Squibb settles with Mass., other states over Abilify marketing
Bizjournals.com
Thu, 12/8/16 - 11:22 pm
Bristol-Myers Squibb
Abilify
antipsychotics
Bristol-Myers Squibb Saw Improved Eliquis Sales in 3Q16
Market Realist
Mon, 11/28/16 - 11:27 pm
Bristol-Myers Squibb
Eliquis
blood thinners
How Did Bristol-Myers Squibb’s Blockbuster Oncology Drug Perform?
Market Realist
Mon, 11/28/16 - 09:43 am
Opdivo
Bristol-Myers Squibb
Bristol’s Opdivo Has One Eye on Advanced Bladder Cancer
Market Realist
Tue, 11/22/16 - 11:29 am
Bristol-Myers Squibb
Opdivo
bladder cancer
Brace Yourself: AstraZeneca Could Be a Fourth Entrant into the PD-1/PD-L1 Drug Class
Market Realist
Mon, 11/21/16 - 11:39 am
AstraZeneca
anti-PD-L1
durvalumab
Opdivo
Keytruda
Tecentriq
Bristol-Myers Squibb
Roche
Merck
Understanding Bristol’s Blockbuster: Opdivo’s Edge over Keytruda
Market Realist
Sat, 11/19/16 - 11:17 am
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
Japan sets 50 pct price cut for Bristol Myers' Opdivo cancer drug
Yahoo/Reuters
Thu, 11/17/16 - 09:47 am
Japan
Bristol-Myers Squibb
Opdivo
drug pricing
non-small cell lung cancer
Bristol's Bid To Get Ahead In Head And Neck
Seeking Alpha
Tue, 11/15/16 - 09:17 am
Bristol-Myers Squibb
head and neck cancer
Opdivo
Keytruda
Merck
Bristol-Myers, Nitto Ink NASH, Fibrosis Deal
Investopedia
Mon, 11/14/16 - 09:53 am
Bristol-Myers Squibb
Nitto
NASH
fibrosis
Bristol-Myers pens $100M NASH, fibrosis drug deal with Japan’s Nitto
Fierce Biotech
Fri, 11/11/16 - 09:52 am
Bristol-Myers Squibb
M&A
NASH
fibrosis
Japan
Nitto
Bristol-Myers' Opdivo succeeds in key stomach cancer study
Yahoo/Reuters
Thu, 11/10/16 - 11:02 am
Bristol-Myers Squibb
Opdivo
stomach cancer
Some Immuno-Oncology Drugs Carry Risk of Rare Heart Damage
Xtalks
Mon, 11/7/16 - 09:17 pm
immuno-oncology
heart damage
Opdivo
Yervoy
Bristol-Myers Squibb
anti-PD-1 immunotherapy
New Bristol-Myers Squibb Research on Opdivo (nivolumab) Monotherapy and in Combination With Yervoy (ipilimumab) at SMR 2016 Congress Reinforces Immuno-Oncology Leadership and Scientific Expertise in Melanoma
Yahoo
Mon, 10/31/16 - 09:08 am
Bristol-Myers Squibb
Opdivo
Yervoy
melanoma
Bristol-Myers reshapes operations in wake of Opdivo miss
BioPharma Dive
Thu, 10/27/16 - 10:47 pm
Bristol-Myers Squibb
reorganization
Opdivo
Bristol hikes 2016 profit forecast as top drugs deliver, shares jump
Yahoo/Reuters
Thu, 10/27/16 - 09:38 am
Bristol-Myers Squibb
earnings

Pages